Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
84.03
+4.10 (5.13%)
At close: May 20, 2026, 4:00 PM EDT
84.16
+0.13 (0.15%)
After-hours: May 20, 2026, 7:56 PM EDT
Globus Medical Analyst Ratings
Total Analysts
14
Consensus Rating
Buy
Price Target
$102.38
Upside
+21.84%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $115 → $120 | Buy | Maintains | $115 → $120 | +42.81% | May 8, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $104 → $103 | Buy | Maintains | $104 → $103 | +22.58% | May 8, 2026 |
| Needham | Needham | Strong Buy Maintains $114 → $117 | Strong Buy | Maintains | $114 → $117 | +39.24% | May 8, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $98 → $104 | Buy | Maintains | $98 → $104 | +23.77% | Feb 26, 2026 |
| Barclays | Barclays | Buy Maintains $118 → $123 | Buy | Maintains | $118 → $123 | +46.38% | Feb 25, 2026 |
| Needham | Needham | Strong Buy Maintains $112 → $114 | Strong Buy | Maintains | $112 → $114 | +35.67% | Feb 25, 2026 |
| Needham | Needham | Hold → Strong Buy Upgrades $112 | Hold → Strong Buy | Upgrades | $112 | +33.29% | Jan 30, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $105 → $112 | Strong Buy | Maintains | $105 → $112 | +33.29% | Jan 9, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $90 → $115 | Buy | Reiterates | $90 → $115 | +36.86% | Jan 8, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $90 → $105 | Strong Buy | Maintains | $90 → $105 | +24.96% | Dec 17, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $92 → $100 | Buy | Maintains | $92 → $100 | +19.01% | Dec 17, 2025 |
| Freedom Capital Markets | Freedom Capital Markets | Hold Initiates $87 | Hold | Initiates | $87 | +3.53% | Dec 17, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $70 → $100 | Buy | Maintains | $70 → $100 | +19.01% | Dec 2, 2025 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $93 → $105 | Strong Buy | Reiterates | $93 → $105 | +24.96% | Nov 18, 2025 |
| Barclays | Barclays | Buy Maintains $106 → $114 | Buy | Maintains | $106 → $114 | +35.67% | Nov 10, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $88 → $92 | Buy | Maintains | $88 → $92 | +9.48% | Nov 7, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.